1. Home
  2. MAGN vs KMDA Comparison

MAGN vs KMDA Comparison

Compare MAGN & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MAGN
  • KMDA
  • Stock Information
  • Founded
  • MAGN 1864
  • KMDA 1990
  • Country
  • MAGN United States
  • KMDA Israel
  • Employees
  • MAGN N/A
  • KMDA N/A
  • Industry
  • MAGN Paper
  • KMDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • MAGN Basic Materials
  • KMDA Health Care
  • Exchange
  • MAGN Nasdaq
  • KMDA Nasdaq
  • Market Cap
  • MAGN 422.2M
  • KMDA 392.2M
  • IPO Year
  • MAGN N/A
  • KMDA N/A
  • Fundamental
  • Price
  • MAGN $11.76
  • KMDA $6.63
  • Analyst Decision
  • MAGN Hold
  • KMDA Strong Buy
  • Analyst Count
  • MAGN 1
  • KMDA 2
  • Target Price
  • MAGN $14.00
  • KMDA $13.00
  • AVG Volume (30 Days)
  • MAGN 653.8K
  • KMDA 52.4K
  • Earning Date
  • MAGN 11-15-2025
  • KMDA 11-12-2025
  • Dividend Yield
  • MAGN N/A
  • KMDA 3.01%
  • EPS Growth
  • MAGN N/A
  • KMDA 27.97
  • EPS
  • MAGN N/A
  • KMDA 0.32
  • Revenue
  • MAGN $2,919,000,000.00
  • KMDA $169,517,000.00
  • Revenue This Year
  • MAGN $49.20
  • KMDA $14.49
  • Revenue Next Year
  • MAGN $5.03
  • KMDA $10.12
  • P/E Ratio
  • MAGN N/A
  • KMDA $20.86
  • Revenue Growth
  • MAGN 34.21
  • KMDA 9.67
  • 52 Week Low
  • MAGN $10.33
  • KMDA $5.18
  • 52 Week High
  • MAGN $26.78
  • KMDA $9.16
  • Technical
  • Relative Strength Index (RSI)
  • MAGN 53.03
  • KMDA 38.27
  • Support Level
  • MAGN $11.10
  • KMDA $6.76
  • Resistance Level
  • MAGN $11.93
  • KMDA $6.89
  • Average True Range (ATR)
  • MAGN 0.47
  • KMDA 0.14
  • MACD
  • MAGN 0.14
  • KMDA -0.01
  • Stochastic Oscillator
  • MAGN 79.67
  • KMDA 24.68

About MAGN Magnera Corporation Common Stock

Magnera Corp formerly Glatfelter Corporation manufactures and sells a variety of paper and fiber products. The company's reportable segments are; Composite Fibers, Spunlace. and Airlaid Materials. The Airlaid Materials segment which is also its key revenue generating segment, is a supplier of cellulose-based airlaid nonwoven materials used to manufacture consumer products for end-user markets. The Airlaid Materials segment produces materials used in feminine hygiene, specialty wipes, tabletop, home care, and other consumables. Geographically, the company derives majority of its revenue from Americas and rest from Europe, Middle East, Africa and Asia Pacific markets.

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Share on Social Networks: